IRIS
ESPOSITO, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.245
NA - Nord America 17.978
AS - Asia 11.647
SA - Sud America 3.511
Continente sconosciuto - Info sul continente non disponibili 879
AF - Africa 310
OC - Oceania 25
Totale 53.595
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.392
RU - Federazione Russa 10.134
SG - Singapore 4.973
CN - Cina 3.196
BR - Brasile 2.965
IE - Irlanda 2.199
SE - Svezia 1.815
IT - Italia 1.690
HK - Hong Kong 1.172
DE - Germania 686
VN - Vietnam 635
FR - Francia 506
GB - Regno Unito 443
PL - Polonia 424
UA - Ucraina 421
FI - Finlandia 348
IN - India 330
BD - Bangladesh 303
CA - Canada 274
AR - Argentina 186
MX - Messico 154
TR - Turchia 137
NL - Olanda 130
AT - Austria 113
ID - Indonesia 107
JP - Giappone 107
ZA - Sudafrica 102
IQ - Iraq 98
EC - Ecuador 93
BE - Belgio 86
PK - Pakistan 81
UZ - Uzbekistan 72
CO - Colombia 70
ES - Italia 70
VE - Venezuela 69
MA - Marocco 67
MY - Malesia 47
CL - Cile 41
AE - Emirati Arabi Uniti 39
IR - Iran 36
JO - Giordania 32
PY - Paraguay 32
SA - Arabia Saudita 32
CR - Costa Rica 31
TN - Tunisia 28
LT - Lituania 27
PH - Filippine 27
CZ - Repubblica Ceca 26
NP - Nepal 25
JM - Giamaica 24
PE - Perù 22
KE - Kenya 21
AZ - Azerbaigian 20
DZ - Algeria 20
AU - Australia 19
KG - Kirghizistan 19
UY - Uruguay 19
EG - Egitto 18
IL - Israele 18
OM - Oman 17
TH - Thailandia 17
DO - Repubblica Dominicana 16
GT - Guatemala 16
PS - Palestinian Territory 16
TW - Taiwan 14
HU - Ungheria 13
BO - Bolivia 12
PA - Panama 12
CI - Costa d'Avorio 11
HN - Honduras 11
KR - Corea 11
SV - El Salvador 11
CH - Svizzera 10
KZ - Kazakistan 10
LB - Libano 10
RS - Serbia 10
NO - Norvegia 9
PT - Portogallo 9
AL - Albania 8
AO - Angola 8
BG - Bulgaria 8
BY - Bielorussia 8
GE - Georgia 8
RO - Romania 8
TT - Trinidad e Tobago 8
EE - Estonia 7
NI - Nicaragua 7
ET - Etiopia 6
LA - Repubblica Popolare Democratica del Laos 6
BB - Barbados 5
BS - Bahamas 5
DK - Danimarca 5
EU - Europa 5
GR - Grecia 5
LV - Lettonia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
XK - ???statistics.table.value.countryCode.XK??? 5
Totale 52.643
Salva come PNG Salva come JPEG
Città #
Ashburn 3.040
Moscow 2.966
Singapore 2.466
Dublin 2.198
Dallas 1.679
Chandler 1.614
Nyköping 1.215
Hong Kong 1.163
Beijing 942
San Jose 914
Jacksonville 830
Council Bluffs 586
The Dalles 529
Messina 444
Los Angeles 406
Princeton 404
Warsaw 399
Dearborn 348
Lauterbourg 333
New York 324
Medford 313
Des Moines 265
Boardman 260
Cambridge 251
São Paulo 238
Munich 237
Ann Arbor 232
Buffalo 194
Ho Chi Minh City 191
Santa Clara 179
Tianjin 153
Guangzhou 135
Hanoi 131
Lancaster 129
Redondo Beach 121
Orem 108
Rome 108
Houston 107
Rio de Janeiro 105
Shenyang 101
Jinan 100
Milan 94
Tokyo 90
Wilmington 88
Montreal 83
Brussels 82
Vienna 79
Catania 73
Frankfurt am Main 73
Nanjing 73
Belo Horizonte 67
Chennai 66
Atlanta 65
Chicago 65
Pune 64
San Mateo 64
Brooklyn 62
Tashkent 62
Ottawa 61
Shanghai 61
Woodbridge 61
London 57
Cologne 53
Turku 53
Johannesburg 52
Phoenix 52
Mexico City 51
Hyderabad 50
San Francisco 50
Shenzhen 50
Baghdad 49
Denver 49
Dong Ket 48
Hebei 48
Jakarta 48
Zhengzhou 47
Ningbo 46
Curitiba 45
Seattle 44
Amsterdam 43
Columbus 43
Stockholm 43
Haikou 42
Brasília 41
Palermo 40
Düsseldorf 39
Campinas 37
Boston 36
Guayaquil 36
Manchester 35
Poplar 35
Porto Alegre 35
Helsinki 34
Nuremberg 34
Istanbul 33
Nanchang 33
Salvador 33
Dhaka 32
Toronto 32
Hangzhou 31
Totale 29.550
Salva come PNG Salva come JPEG
Nome #
Dimethyl fumarate reduces inflammatory responses in experimental colitis 288
Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. 258
2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation 251
Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. 249
Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein 240
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 237
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 233
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats 233
A Systematic Review and Meta-Analysis of the Association between the FV H1299R Variant and the Risk of Recurrent Pregnancy Loss 231
PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury 231
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 222
Influence of coagulase-negative staphylococci as potential probiotics on Dry Eye 222
Celenterati Cnidari come modello per lo studio di tossicità da metalli pesanti. 220
MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma 220
3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease 219
Absence of endogenous Interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. 216
B Cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord 213
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome 211
Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies 209
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation 209
Effects of Physical Exercise and Motor Activity on Oxidative Stress and Inflammation in Post Mastectomy Pain Syndrome 208
Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-alpha 206
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 203
Beneficial effect of tempol, a membrane-permeable radical scavenger, on inflammation and osteoarthritis in in vitro models 203
Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury. 200
Correction to: Potential eye drop based on a calix[4]arene nanoassembly for curcumin delivery: Enhanced drug solubility, stability, and anti-inflammatory effect (Molecular Pharmaceutics (2017) 14:5 (1610-1622) DOI: 10.1021/acs.molpharmaceut.6b01066) 200
BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine 199
Protein Hydrolysates from Anchovy (Engraulis encrasicolus) Waste: In Vitro and In Vivo Biological Activities 195
Antioxidant and anti-inflammatory effect of nrf2 inducer dimethyl fumarate in neurodegenerative diseases 195
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury 195
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 194
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma 194
Anti-inflammatory and Antioxidant Effects of Flavonoid-Rich Fraction of Bergamot Juice (BJe) in a Mouse Model of Intestinal Ischemia/Reperfusion Injury 192
Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. 191
B Cell-Targeted Therapy with Anti-CD20 Monoclonal Antibody Reduced Secondary Tissue Damage and Enhanced Behavioural Recovery Following Experimental Spinal Cord Injury in Mice 190
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 190
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy 189
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man 189
Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury 187
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 187
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice 187
Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury 185
Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study 185
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 184
A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock 183
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 180
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 177
A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury. 177
Ethyl-piruvate reduces the developments of zymosine-induced generalized inflammatory in mice 176
Adenosine A2A receptor selective stimulation reduces mitogen activated protein kinases in spinal cord injury: activation of jnk is reduced in oligodendrocytes 176
Palmitoylethanolamide Reduces Early Renal Dysfunction and Injury Caused by Experimental Ischemia and Reperfusion in Mice. 176
Carbon dots as promising tools for cancer diagnosis and therapy 176
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion 175
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 173
Role of melatonin supplementation in neurodegenerative disorders. 173
Absence of peroxisome proliferators activated receptors alpha (PPAR-) enhanced the multiple organ failure induced by zymosan. 173
Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice 172
Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents 172
A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo 170
Aspetti tossicologici di estratto crudo da Pelagia noctiluca (Cnidaria: Scyphozoa). 169
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2 169
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome 166
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury 166
Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury 166
Effects of Physical Exercise and Motor Activity on Depression and Anxiety in Post-Mastectomy Pain Syndrome 165
N-palmitoylethanolamine administration ameliorates the clinical manifestation and progression of experimental autoimmune encephalomyelitis in rodents 165
Adenosine A2a receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma (Biological Regulators and Homeostatical Agents (73)) 165
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-alpha MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE. 164
TAK1 inhibitor enhances the therapeutic treatment for glioblastoma 164
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 163
Evaluation of the nutraceutical Palmitoylethanolamide in reducing intraocular pressure (IOP) in patients with glaucoma or ocular hypertension: a systematic review and meta-analysis 162
A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways. 162
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 161
The protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion 161
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 160
Effect of co-ultramicronized palmitoylethanolamide and luteolin association on neurogenesis in a mouse model of spinal cord injury 160
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 159
Dimethyl Fumarate (DMF) Alleviated Post-Operative (PO) Pain through the N-Methyl-d-Aspartate (NMDA) Receptors 158
BENEFICIAL EFFECTS OF ETHYL PYRUVATE IN A MOUSE MODEL OF SPINAL CORD INJURY. 158
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia 158
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 158
Glycogen synthase kinase 3 beta inhibition reduces the development of nonseptic shock induced by zymosan in mice 157
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness 156
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α. 156
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 156
Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance 154
Role of Dkk-3 in the neoplastic progression of meningiomas. Could it represent a new therapeutic target? 154
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 152
Au, Pd and maghemite nanofunctionalized hydroxyapatite scaffolds for bone regeneration 152
Autophagy and Liver Diseases 151
Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury 150
Potential Therapeutic Effects of PPAR Ligands in Glioblastoma 148
GW0742, a high-affinity PPAR -beta/delta agonist, inhibits acute lung injury in mice 147
P12.05 Role of Dkk-3 in the neoplastic progression of meningiomas. Could it represent a new therapeutic target? 147
Inhibition of Poly(ADP-Ribose) Polymerase Activity Modulates Autophagy Induced by Experimental Spinal Cord Trauma 147
PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice 146
Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury 146
Palmitoylethanolamide ameliorates development of colitis caused by injection of dinitrobenzene sulfonic acid (DNBS) in mice 146
GREEN TEA POLYPHENOL EXTRACT ATTENUATES ZYMOSAN-INDUCED NON SEPTICK SHOCK IN MICE 145
A controlled cortical impact preclinical model of traumatic brain injury 145
Totale 18.323
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.270
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.305 0 173 55 92 117 36 181 91 75 132 470 883
2022/20236.430 533 524 288 528 465 644 95 356 2.705 46 178 68
2023/20241.836 128 271 108 156 157 404 81 101 23 99 35 273
2024/20258.657 164 89 250 404 410 248 278 1.590 2.137 505 1.046 1.536
2025/202626.685 1.342 1.594 2.020 1.962 2.130 5.445 3.168 3.073 3.241 1.340 577 793
2026/20271.885 732 1.153 0 0 0 0 0 0 0 0 0 0
Totale 53.595